Einar Stefánsson (Einar Stefansson)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Diabetic Retinopathy

Top Venues

Acta ophthalmologica

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed Abu El-Asrar, Abdulrahman F AlBloushi, Abdullah Alzubaidi, Priscilla W Gikandi, Einar Stefánsson
Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt-Koyanagi-Harada disease. Acta ophthalmologica 102 (6) (2024)
Ahmed Abu El-Asrar, Abdulrahman F AlBloushi, Abdullah Alzubaidi, Priscilla W Gikandi, Einar Stefánsson
Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt-Koyanagi-Harada disease. Acta ophthalmologica (2024)
Kai Kaarniranta, Einar Stefánsson
The VL Nordic Congress of Ophthalmology 2024. Acta ophthalmologica 102 (5) (2024)
Kai Kaarniranta, Einar Stefánsson
Acta Ophthalmologica stands on top level after 100 years. Acta ophthalmologica (2024)
Kai Kaarniranta, Einar Stefánsson
The VL Nordic Congress of Ophthalmology 2024. Acta ophthalmologica (2024)
Kai Kaarniranta, Einar Stefánsson
Acta Ophthalmologica for 100 years. Acta ophthalmologica 101 (1) (2023)
Oliver Niels Klefter, Jesper Høiberg Erichsen, Mathias Møller Hansen, Lars Morten Holm, Sveinn Hakon Hardarson, Einar Stefánsson, Kessel Line
Evaluation of a retinal oximetry image quality indicator in patients with cataract. Acta ophthalmologica (2023)
Kai Kaarniranta, Einar Stefánsson
Geographic atrophy ends Acta Ophthalmologica centennial. Acta ophthalmologica 101 (8) (2023)
Kai Kaarniranta, Einar Stefánsson
Acta Ophthalmologica 2021. Acta ophthalmologica 100 (5) (2022)
Ahmed Abu El-Asrar, Abdulrahman F AlBloushi, Priscilla W Gikandi, Abdullah Alzubaidi, Einar Stefánsson
Changes in ocular blood flow and retinal oxygen metabolism during immunosuppressive therapy for initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta ophthalmologica 100 (6) (2022)
Laura Lorenzo-Soler, Pitsiree Praphanwittaya, Olof Birna Olafsdottir, Iris Myrdal Kristinsdottir, Gudrun Marta Asgrimsdottir, Thorsteinn Loftsson, Einar Stefánsson
Topical noninvasive retinal drug delivery of a tyrosine kinase inhibitor: 3% cediranib maleate cyclodextrin nanoparticle eye drops in the rabbit eye. Acta ophthalmologica 100 (7) (2022)
Kai Kaarniranta, Einar Stefánsson
The state of your journal Acta Ophthalmologica 2020. Acta ophthalmologica 99 (5) (2022)
Kai Kaarniranta, Einar Stefánsson
Successful years of collaboration between Acta Ophthalmologica and the European Association for Vision and Eye Research. Acta ophthalmologica 99 (3) (2021)
Thorsteinn Loftsson, Einar Stefánsson
Aqueous eye drops containing drug/cyclodextrin nanoparticles deliver therapeutic drug concentrations to both anterior and posterior segment. Acta ophthalmologica (2021)
Kai Kaarniranta, Einar Stefánsson
The most successful year in the history of Acta Ophthalmologica. Acta ophthalmologica 99 (2) (2021)
Gwen Weisner, Søren Leer Blindbæk, Fang Yao Tang, Carol Yim-Lui Cheung, Jan Erik Henriksen, Einar Stefánsson, Tunde Peto, Jakob Grauslund
Non-invasive structural and metabolic retinal markers of disease activity in non-proliferative diabetic retinopathy. Acta ophthalmologica 99 (7) (2021)
Wouter B H J Vehmeijer, Kelly Jonkman, Sveinn H Hardarson, Leon Aarts, Einar Stefánsson, Albert Dahan, Nicoline E Schalij-Delfos
Retinal oximetry with a prototype handheld oximeter during hyperoxia. Acta ophthalmologica 99 (8) (2021)